FDA Approves PASCAL Precision System for TEER in Degenerative Mitral Regurgitation
September 16th 2022Announced on September 15 by Edwards Lifesciences Corporation, the PASCAL Precision transcatheter valve repair system has received approval for transcatheter edge-to-edge repair in patients with degenerative mitral regurgitation.
Don't Miss a Beat: oHCM and Mavacamten, with Anjali Owens, MD
June 9th 2022In the latest edition of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, are joined by special guest Anjali Owens, MD. An assistant professor of medicine and medical director of the Center for Inherited Cardiac Disease at the Perelman School of Medicine, Owens takes our hosts on a deep dive into the current state of management for oHCM and the impact of the US FDA's approval of mavacamten.
Mitral Annulus Calcification Can Predict Increased Risk of Mortality, Mitral Valve Dysfunction
June 2nd 2022A new study from the Mayo Clinic provides insight into the prognostic value of mitral annulus calcification for predicting risk of mortality, regardless of whether or not patients had subsequent mitral valve dysfunction.
Study Sounds Warning on Calcium Supplementation in Aortic Stenosis
May 2nd 2022An analysis of data from the Cleveland Clinic Echocardiography database provides an overview of the association between the use of calcium supplements with increased risk of mortality and worsening stenosis among older patients with aortic stenosis.
Ross Procedure Safe, Effective For Adults Undergoing Aortic Valve Surgery
February 23rd 2022An analysis comparing 15-year outcomes following Ross procedure and biological or mechanical aortic valve replacement provides insight into the risk of mortality and other adverse outcomes associated with each procedure.